Phased variants improve DLBCL minimal residual disease detection at the end of therapy.
David Matthew Kurtz,Jacob J. Chabon,Joanne Soo,Lyron Co Ting Keh,Stefan Alig,Andre Schultz,Michael C. Jin,Florian Scherer,Alexander F. M. Craig,Chih Long Liu,Ulrich Duehrsen,Andreas Huettmann,Rene-Olivier Casasnovas,Jason Westin,Mark J. Roschewski,Wyndham Hopkins Wilson,Gianluca Gaidano,Davide Rossi,Maximilian Diehn,Ash A. Alizadeh JOURNAL OF CLINICAL ONCOLOGY(2021)
AI 理解论文
溯源树
样例